Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Medical Officer sold 7,771 shares at $0.79 ($6,139)
  6. 4 Exercise or conversion Director acquired 5,701 shares (option exercise)
  7. 4 Planned sale President and CEO sold 46,999 shares at $0.82 ($38,539)
  8. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.86 ($17,200)
  9. 4 Open-market sale General Counsel and Secretary sold 12,172 shares at $1.07 ($13,024)
  10. 4 Open-market sale Chief Medical Officer sold 9,473 shares at $1.07 ($10,136)
  11. 4 Grant or award Chief Research Officer acquired 12,157 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 11,605 shares (grant or award)
  13. 4 Exercise or conversion VP & Corporate Controller acquired 12,722 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 14 · 269 filings